Kenji Kubara

558 total citations
12 papers, 346 citations indexed

About

Kenji Kubara is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Kenji Kubara has authored 12 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Kenji Kubara's work include RNA Interference and Gene Delivery (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Immunotherapy and Immune Responses (2 papers). Kenji Kubara is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Immunotherapy and Immune Responses (2 papers). Kenji Kubara collaborates with scholars based in Japan and United States. Kenji Kubara's co-authors include Yuta Suzuki, Keita Kondo, Kazuto Yamazaki, Taro Hihara, Kenji Hyodo, Tatsuhiro Ishida, Takuya Suzuki, Hiroshi Ishihara, Kappei Tsukahara and Masashi Ito and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Controlled Release and Archives of Biochemistry and Biophysics.

In The Last Decade

Kenji Kubara

10 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Kubara Japan 8 276 67 64 33 31 12 346
Pad Chivukula United States 8 302 1.1× 62 0.9× 72 1.1× 89 2.7× 14 0.5× 10 400
Hyein Jung South Korea 6 289 1.0× 64 1.0× 41 0.6× 45 1.4× 40 1.3× 12 393
Emily Freund United States 7 332 1.2× 200 3.0× 100 1.6× 42 1.3× 10 0.3× 11 485
E. Sathyajith Kumarasinghe United States 3 555 2.0× 138 2.1× 105 1.6× 92 2.8× 36 1.2× 4 634
Miaojin Zhu China 7 130 0.5× 94 1.4× 69 1.1× 14 0.4× 16 0.5× 12 339
Benjamin Brigham United States 4 289 1.0× 36 0.5× 20 0.3× 28 0.8× 25 0.8× 5 325
Oxana V. Denisova Finland 7 160 0.6× 70 1.0× 37 0.6× 16 0.5× 9 0.3× 10 333
Elham Fakhr Germany 7 212 0.8× 79 1.2× 29 0.5× 53 1.6× 8 0.3× 9 329
Sibei Lei China 10 203 0.7× 93 1.4× 57 0.9× 55 1.7× 41 1.3× 14 342
Pedro Morais United States 6 327 1.2× 26 0.4× 37 0.6× 40 1.2× 7 0.2× 11 391

Countries citing papers authored by Kenji Kubara

Since Specialization
Citations

This map shows the geographic impact of Kenji Kubara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Kubara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Kubara more than expected).

Fields of papers citing papers by Kenji Kubara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Kubara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Kubara. The network helps show where Kenji Kubara may publish in the future.

Co-authorship network of co-authors of Kenji Kubara

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Kubara. A scholar is included among the top collaborators of Kenji Kubara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Kubara. Kenji Kubara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yamazaki, Kazuto, Kenji Kubara, Yuji Mano, et al.. (2025). Species-specific gene expression manipulation in humanized livers of chimeric mice via siRNA-encapsulated lipid nanoparticle treatment. Molecular Therapy — Methods & Clinical Development. 33(2). 101466–101466. 2 indexed citations
2.
Agarwala, Kishan, Kenji Kubara, Boris M. Seletsky, Koji Sagane, & Bruce A. Littlefield. (2025). Eribulin's exclusive binding to microtubule plus ends results from discrimination between GTP and GDP forms of β-tubulin. Archives of Biochemistry and Biophysics. 771. 110482–110482.
3.
Kubara, Kenji, et al.. (2025). Ionizable lipid chemistry in lipid nanoparticles determines delivery efficiency to hepatic stellate cells. Journal of Controlled Release. 385. 114055–114055.
4.
Suzuki, Yuta, Yumi Itoh, Kenji Kubara, et al.. (2025). In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection. Molecular Therapy — Nucleic Acids. 36(1). 102467–102467. 3 indexed citations
5.
Kubara, Kenji, Kazuto Yamazaki, Keita Kondo, et al.. (2024). Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines. Molecular Therapy. 32(3). 704–721. 21 indexed citations
6.
Sato, Shinya, et al.. (2024). Understanding the Manufacturing Process of Lipid Nanoparticles for mRNA Delivery Using Machine Learning. Chemical and Pharmaceutical Bulletin. 72(6). 529–539. 17 indexed citations
7.
Yamazaki, Kazuto, Kenji Kubara, Yuta Suzuki, et al.. (2023). Multivalent mannose-conjugated siRNA causes robust gene silencing in pancreatic macrophages in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 183. 61–73. 9 indexed citations
8.
Yamazaki, Kazuto, Kenji Kubara, Keita Kondo, et al.. (2023). Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice. Molecular Therapy — Nucleic Acids. 33. 210–226. 23 indexed citations
9.
Suzuki, Yuta, Kenji Kubara, Yohei Mukai, et al.. (2022). Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates. Molecular Therapy — Nucleic Acids. 30. 226–240. 52 indexed citations
10.
Suzuki, Takuya, Yuta Suzuki, Taro Hihara, et al.. (2020). PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production. International Journal of Pharmaceutics. 588. 119792–119792. 161 indexed citations
11.
Kubara, Kenji, Kazuto Yamazaki, Y. Ishihara, et al.. (2018). Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity. Stem Cell Reports. 11(2). 380–394. 18 indexed citations
12.
Koshiba, Takumi, Holly A. Holman, Kenji Kubara, et al.. (2010). Structure-Function Analysis of the Yeast Mitochondrial Rho GTPase, Gem1p. Journal of Biological Chemistry. 286(1). 354–362. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pad Chivukula Breakdown of academic impact, for papers by Hyein Jung Breakdown of academic impact, for papers by Emily Freund Breakdown of academic impact, for papers by E. Sathyajith Kumarasinghe Breakdown of academic impact, for papers by Miaojin Zhu Breakdown of academic impact, for papers by Benjamin Brigham Breakdown of academic impact, for papers by Oxana V. Denisova Breakdown of academic impact, for papers by Elham Fakhr Breakdown of academic impact, for papers by Sibei Lei Breakdown of academic impact, for papers by Pedro Morais
Rankless by CCL
2026